Lesley Ann Bergmeier
Nicolas Dutzan
Patricio C. Smith
Heleen Kraan- 1Centre for Immunobiology and Regenerative Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
- 2Department of Conservative Dentistry, Faculty of Dentistry, University of Chile, Santiago, Chile
- 3School of Dentistry, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
- 4Institute for Translational Vaccinology, Intravacc, Bilthoven, Netherlands
Editorial on the Research Topic
Immunology of the Oral Mucosa
The oral mucosa is host to over 700 species of commensal organisms (HTTP://www.homd.org) and is constantly exposed to potentially inflammatory stimuli, yet, in healthy individuals, acute inflammation is unusual. Waldeyer’s ring and numerous draining lymph nodes provide inductive and effector sites for intense immune activity that maintains the integrity of the mucosal barrier. A state of immune privilege or tolerance is said to exist in the oral mucosa through the induction of T regulatory cells and the production of cytokines that support immuno-suppression of unwanted responses to innocuous antigens (1–3). Several different types of stratified epithelia are present including the lining mucosa, masticatory and specialized mucosa and range from thin non-keratinized sub-lingual and buccal mucosae to thick highly keratinized Gingiva (4) Their functions have direct effects on immune responses, such as the induction of homeostatic Th17 responses by the mechanical damage of mastication (5).
Investigations of the oral cavity range from the first observations of dental plaque by Anton van Leeuwenhoek in the 1660’s to the recently published cell atlas of the oral mucosa (6) and have provided major contributions to the understanding of mucosal immune responses (7). Seminal studies emphasizing the importance of the ecological balance of the oral microbiota and the host have described dysbiosis as a driving force contributing to oral (and systemic) diseases (8).
This Research Topic has attracted an eclectic series of reviews, original research, case studies and hypotheses which are reflective of the importance and broad range of oral immunology studies and the applicability of the oral mucosa for diagnosis, intervention and prevention of disease.
Suárez et al. have compared the immune niches of the oral and gastrointestinal mucosa in terms of their anatomy, cell to cell communication, antigen handling, signaling pathways and systemic consequences in disease pathogenesis. A greater diversity of dendritic cells in the oral cavity (9), and potential synergistic interaction between TLRs and NOD receptors results in a measured response to oral bacteria (10). TLR splice variants have been observed in the buccal mucosa of the autoinflammatory condition Behçet’s Disease (11) where dysregulated antigen recognition could contribute to inflammatory profiles. Suárez et al. conclude that microbial translocation contributes to systemic disease and emphasize the bidirectionality of the interface between the oral and gastrointestinal mucosa.
An intriguing paper on obstructive sleep apnea by Samiento Varón et al. suggests that children with hypertrophied tonsils have abnormally active pro-inflammatory B and T cells, where modulation of the microbiome allows penetration into tonsil tissues and potential breaching of the epithelial barrier and is supported by previous studies (12).
Characterization of the human oral mucosa cell atlas suggests that a stromal-neutrophil axis regulates tissue immunity (6). Metcalfe et al. have reviewed the role of polarized phagocytes in the oral mucosa, suggesting a particular heterogeneity of neutrophils in this tissue. The role of neutrophils in the pathology of the periodontal pocket was recently reviewed (13, 14) and up-regulation of neutrophil activation in inflammatory disease with oral manifestations has been described (15). Ozuna et al. have demonstrated that gram-negative bacteria associated with periodontal disease are able to highjack neutrophil function by upregulating azurophilic granule exocytosis as survival mechanism. The plasticity of neutrophils in oral tissues is highlighted suggesting that these cells are underestimated (16). The use of the neutrophil/lymphocyte ratio was suggested as an indicator of disease progression (17).
Zhang et al. have reviewed the role of T-regulatory cells in the context of Head and Neck cancers as well as periodontitis. Other studies suggest that a uniquely large population of FOXp3+ Tregs are found in the oral mucosa (18). Tregs promote the generation of IL-17-producing Th17 cells by consuming IL-2, an important survival factor, but also a negative regulator of Th17 differentiation (19).
IL-17 is an important cytokine in the oral mucosa and has been shown to regulate host-microbe interaction (20) as well as being up-regulated in response to mastication (5). Its role in the pathology of periodontitis is well documented (21). In contrast some Th17 cells act as negative regulators of inflammation by secreting IL-10 and are thus regarded as non-pathogenic (22). In this context oral mucositis was shown to be mitigated by IL-17 receptor signalling in a clinically relevant murine model of irradiation induced mucositis which might lead to therapeutic interventions (Saul-McBeth et al.)
The use of pro-biotics is a topic of popular interest for restoring/maintaining the normal microbiome (23, 24). Wang et al. suggest this might be a useful adjunct in oral cancer therapy as demonstrated in a mouse model of mucositis using Strep. salivarius K12 to help reconstitute the dysbiotic oral microbiome.
Other materials have been suggested as potential down regulators of inflammation and Mooney et al. present a proof-of-concept study using Quercetin, a plant based polyphenolic flavonoid, to modify the oral microbiome both in vivo and in vitro. This flavonoid has been shown to have health benefits in humans and animals (25) and works through modulation of the NF-кB:A20 axis.
Molecular profiling of multiple cell types and multiple effector molecules provides large amounts of data and moves analysis of health and disease from reductionist theory to systems biology. Profiles of multiple pro-resolving lipid mediators have been investigated by Lee et al. in periodontal inflammation, suggesting a correlation between these molecules, receptor genes and the sub-gingival microbiome that have the potential to skew the periodontal microbiome. Failure to resolve inflammation was investigated by Alvarez et al. in experimental periodontitis where the T cell component was inhibited, but neutrophil and macrophage infiltration was unaffected by early administration of RvE1. Previous studies have suggested that salivary levels of lipid mediators might be used as indicators of health and disease of the periodontium (26)
Salivary flow in the oral cavity is greater than 1 liter/day and the surface epithelium is constantly in turnover. About 70% of the total numbers of lymphocytes are found in the gut (27) and the compartmentalization of the mucosal immune system has been investigated, particularly in the context of vaccination (28–30). While the systemic and mucosal immune systems are regarded as distinct there is constant communication between them in order to maintain the homeostasis of “health”. Many systemic diseases present with oral manifestations and oral health has a considerable impact on systemic disease (31).
Classically IgA has been regarded as the predominant functional antibody in saliva and during the SARS-CoV-2(Covid) pandemic it has been surprising that this antibody has been somewhat neglected (32). Most analysis of immune responses have concentrated on the serum IgG response to this mucosal infection.
Chellamuthu et al. present data on IgG antibodies in the saliva of SARS-CoV-2 infected individuals and suggest this would be an effective alternative to serum-based assays. Secretory IgA (sIgA) antibodies in individuals that have not been infected with SARS-CoV-2 have been reported (33). However, these cross-reactive antibodies may be a result of the ability of sIgA to bind virus in a non- specific manner as part of its function of virus exclusion from mucosal surfaces. While the contribution of IgA to the immune response to SARS-CoV-2 requires further investigation, a recent review elaborated a greater degree of interaction between IgG and IgA (as well as IgM and IgD) in driving sIgA responses in increasingly complex cross-talk between the mucosal and systemic systems (34).
The detection of soluble mediators of inflammation (cytokines) in serum compared with saliva was highlighted by Novak et al. Salivary cytokine profiling would be less invasive than blood sampling and might reveal more accurately, either disease activity or disease progression in individuals with oral manifestations of disease, and host and environmental influences (35).
Immunohistochemical signatures as clinical monitoring for mucosal melanoma are presented by Xu et al. This disease is difficult to diagnose with a poor prognosis and methods that improve outcomes are very important (36).
Similarly, genetic markers can provide indicators of progression, manifestations and the propensity for diseases. A case report of a family with hereditary gingival fibromatosis (HGF) presented by Gao et al. suggest that the presence of high levels of Human β defensins in the gingival tissues had a beneficial effect in preventing the thickening of the gingiva in this condition.
Qian et al. have used transcriptomic analysis to identify a new set of inflammation promoting cell subsets in chronic periodontitis. Their study shows NLRP3+ macrophage involvement and expression of HLA-DR on endothelial cells and CXCL13+ fibroblasts were highly associated with regulatory profiles in Asian patients. This is consistent with recent papers on the involvement of NLRP3+ cells in periodontal disease (37) and in periodontitis associated with uncontrolled type-2 diabetes (38).
A recurring theme in several submissions is the diversity and plasticity of the cells of the oral mucosa. This may reflect the observations that the oral mucosa, like fetal tissues heals quickly without scarring. The immaturity and diversity of some cell types within the oral mucosa may be the key to the unique physiology of this tissue.
Future studies specifically designed to further develop the oral mucosa and saliva as analytical tools for both oral and systemic disease are an exciting prospect both in the context of new technologies such as multi-colored flow cytometry, multiplex analysis and fast affordable genetic analysis and as potential routes for vaccinology and drug delivery (39).
Author Contributions
LB drafted the editorial and ND, PS and HK contributed to the final submitted version. All authors contributed to the article and approved the submitted version.
Conflict of Interest
Author HK was employed by company Intravacc.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Novak N, Haberstok J, Bieber T, Allam JP. The Immune Privilege of the Oral Mucosa. Trends Mol Med (2008) 14(5):191–8. doi: 10.1111/cei.13483
2. Allam J-P, Novak N. Mucosal Homeostasis of the Oral Mucosa. In: Bergmeier LA, editor. Oral Mucosa in Health and Disease: A Concise Handbook. Cham: Springer International Publishing (2018). p. 69–76. doi: 10.1007/978-3-319-56065-6_5
3. Pelaez-Prestel HF, Sanchez-Trincado JL, Lafuente EM, Reche PA. Immune Tolerance in the Oral Mucosa. Int J Mol Sci (2021) 22(22):1–14. doi: 10.3390/ijms222212149
4. Nanci A. Ten Cate’s Oral Histology. 8th Ed. St Louis Missouri: Elsevier, Mosby (2013). Available at: https://www.elsevier.com/books/ten-cates-oral-histology/nanci/978-0-323-07846-7.
5. Dutzan N, Abusleme L, Bridgeman H, Greenwell-Wild T, Zangerle-Murray T, Fife ME, et al. On-Going Mechanical Damage From Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier. Immunity (2017) 46(1):133–47. doi: 10.1016/j.immuni.2016.12.010
6. Williams DW, Greenwell-Wild T, Brenchley L, Dutzan N, Overmiller A, Sawaya AP, et al. Human Oral Mucosa Cell Atlas Reveals a Stromal-Neutrophil Axis Regulating Tissue Immunity. Cell (2021) 184(15):4090–104.e15. doi: 10.1016/j.cell.2021.05.013
7. Kiyono H, Azegami T. The Mucosal Immune System: From Dentistry to Vaccine Development. Proc Japan Acad Ser B Phys Biol Sci (2015) 91(8):423–39. doi: 10.2183/pjab.91.423
8. Lamont RJ, Koo H, Hajishengallis G. The Oral Microbiota: Dynamic Communities and Host Interactions. Nat Rev Microbiol (2018) 16(12):745–59. doi: 10.1038/s41579-018-0089-x
9. de Winde CM, Munday C, Acton SE. Molecular Mechanisms of Dendritic Cell Migration in Immunity and Cancer. Med Microbiol Immunol (2020) 209(4):515–29. doi: 10.1007/s00430-020-00680-4
10. Uehara A, Takada H. Synergism Between TLRs and NOD1/2 in Oral Epithelial Cells. J Dent Res (2008) 87(7):682–6. doi: 10.1177/154405910808700709
11. Seoudi N, Bergmeier LA, Hagi-Pavli E, Bibby D, Curtis MA, Fortune F. The Role of TLR2 and 4 in Behçet’s Disease Pathogenesis. Innate Immun (2014) 20(4):412–22. doi: 10.1177/1753425913498042
12. Alasil SM, Omar R, Ismail S, Yusof MY, Dhabaan GN, Abdulla MA. Evidence of Bacterial Biofilms Among Infected and Hypertrophied Tonsils in Correlation With the Microbiology, Histopathology, and Clinical Symptoms of Tonsillar Diseases. Int J Otolaryngol (2013) 2013:408238. doi: 10.1155/2013/408238
13. Vitkov L, Muñoz LE, Schoen J, Knopf J, Schauer C, Minnich B, et al. Neutrophils Orchestrate the Periodontal Pocket. Front Immunol (2021) 12:788766. doi: 10.3389/fimmu.2021.788766
14. Hajishengallis G. New Developments in Neutrophil Biology and Periodontitis. Periodontol 2000 (2020) 82(1):78–92. doi: 10.1111/prd.12313
15. Novak T, Fortune F, Bergmeier L, Khan I, Hagi-Pavli E. Neutrophil Elastase and Endogenous Inhibitors in Behçet’s Disease Saliva. Clin Exp Immunol (2020) 202(1):93–105. doi: 10.1111/cei.13483
16. Domnich M, Riedesel J, Pylaeva E, Kürten CHL, Buer J, Lang S, et al. Oral Neutrophils: Underestimated Players in Oral Cancer. Front Immunol (2020) 11:565683. doi: 10.3389/fimmu.2020.565683
17. Düzlü M, Karamert R, Tutar H, Şahin M, Türkcan A, Yılmaz M. Diagnostic Role of Neutrophil-Lymphocyte Ratio in Oral Cavity Cancers. Niger J Clin Pract (2018) 21(1):49–53. doi: 10.4103/1119-3077.224796
18. Park JY, Chung H, DiPalma DT, Tai X, Park JH. Immune Quiescence in the Oral Mucosa is Maintained by a Uniquely Large Population of Highly Activated Foxp3(+) Regulatory T Cells. Mucosal Immunol (2018) 11(4):1092–102. doi: 10.1038/s41385-018-0027-2
19. Hong C, Luckey MA, Ligons DL, Waickman AT, Park JY, Kim GY, et al. Activated T Cells Secrete an Alternatively Spliced Form of Common γ-Chain That Inhibits Cytokine Signaling and Exacerbates Inflammation. Immunity (2014) 40(6):910–23. doi: 10.1016/j.immuni.2014.04.020
20. Gaffen SL, Moutsopoulos NM. Regulation of Host-Microbe Interactions at Oral Mucosal Barriers by Type 17 Immunity. Sci Immunol (2020) 5(43):1–12. doi: 10.1126/sciimmunol.aau4594
21. Deng J, Lu C, Zhao Q, Chen K, Ma S, Li Z. The Th17/Treg Cell Balance: Crosstalk Among the Immune System, Bone and Microbes in Periodontitis. J Periodontal Res (2021) 57:246–55. doi: 10.1111/jre.12958
22. Wu X, Tian J, Wang S. Insight Into Non-Pathogenic Th17 Cells in Autoimmune Diseases. Front Immunol (2018) 9:1112. doi: 10.3389/fimmu.2018.01112
23. How YH, Yeo SK. Oral Probiotic and its Delivery Carriers to Improve Oral Health: A Review. Microbiol (Reading) (2021) 167(8):1–18. doi: 10.1099/mic.0.001076
24. Davoodvandi A, Fallahi F, Tamtaji OR, Tajiknia V, Banikazemi Z, Fathizadeh H, et al. An Update on the Effects of Probiotics on Gastrointestinal Cancers. Front Pharmacol (2021) 12:680400:680400. doi: 10.3389/fphar.2021.680400
25. Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, et al. Quercetin, Inflammation and Immunity. Nutrients (2016) 8(3):167. doi: 10.3390/nu8030167
26. Tobón-Arroyave SI, Isaza-Guzmán DM, Gómez-Ortega J, Flórez-Alzate AA. Salivary Levels of Specialized Pro-Resolving Lipid Mediators as Indicators of Periodontal Health/Disease Status. J Clin Periodontol (2019) 46(10):978–90. doi: 10.1111/jcpe.13173
27. Pabst R, Russell MW, Brandtzaeg P. Tissue Distribution of Lymphocytes and Plasma Cells and the Role of the Gut. Trends Immunol (2008) 29(5):206–8; author reply 9-10. doi: 10.1016/j.it.2008.02.006
28. Mestecky J, McGhee JR, Michalek SM, Arnold RR, Crago SS, Babb JL. Concept of the Local and Common Mucosal Immune Response. Adv Exp Med Biol (1978) 107:185–92. doi: 10.1007/978-1-4684-3369-2_22
29. Holmgren J, Czerkinsky C. Mucosal Immunity and Vaccines. Nat Med (2005) 11(4 Suppl):S45–53. doi: 10.1038/nm1213
30. Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM. Mucosal Immunity: Implications for Vaccine Development. Immunobiology (1992) 184(2-3):157–79. doi: 10.1016/S0171-2985(11)80473-0
31. Kane SF. The Effects of Oral Health on Systemic Health. Gen Dent (2017) 65(6):30–4. Accession Number: 29099363.
32. Russell MW, Moldoveanu Z, Ogra PL, Mestecky J. Mucosal Immunity in COVID-19: A Neglected But Critical Aspect of SARS-CoV-2 Infection. Front Immunol (2020) 11:611337:611337. doi: 10.3389/fimmu.2020.611337
33. Tsukinoki K, Yamamoto T, Handa K, Iwamiya M, Saruta J, Ino S, et al. Detection of Cross-Reactive Immunoglobulin A Against the Severe Acute Respiratory Syndrome-Coronavirus-2 Spike 1 Subunit in Saliva. PloS One (2021) 16(11):e0249979. doi: 10.1371/journal.pone.0249979
34. Chen K, Magri G, Grasset EK, Cerutti A. Rethinking Mucosal Antibody Responses: IgM, IgG and IgD Join IgA. Nat Rev Immunol (2020) 20(7):427–41. doi: 10.1038/s41577-019-0261-1
35. Ter Horst R, Jaeger M, Smeekens SP, Oosting M, Swertz MA, Li Y, et al. Host and Environmental Factors Influencing Individual Human Cytokine Responses. Cell (2016) 167(4):1111–24.e13. doi: 10.1016/j.cell.2016.10.018
36. Olla D, Neumeister MW. Mucosal Melanoma. Clin Plast Surg (2021) 48(4):707–11. doi: 10.1016/j.cps.2021.05.010
37. García-Hernández AL, Muñoz-Saavedra ÁE, González-Alva P, Moreno-Fierros L, Llamosas-Hernández FE, Cifuentes-Mendiola SE, et al. Upregulation of Proteins of the NLRP3 Inflammasome in Patients With Periodontitis and Uncontrolled Type 2 Diabetes. Oral Dis (2019) 25(2):596–608. doi: 10.1111/odi.13003
38. De Andrade KQ, Almeida-da-Silva CLC, Ojcius DM, Coutinho-Silva R. Differential Involvement of the Canonical and Noncanonical Inflammasomes in the Immune Response Against Infection by the Periodontal Bacteria Porphyromonas Gingivalis and Fusobacterium Nucleatum. Curr Res Microb Sci (2021) 2:100023. doi: 10.1016/j.crmicr.2021.100023
Keywords: oral mucosa, biomarkers, Tregs (regulatory T cells), innate phagocytes, dysbiosis
Citation: Bergmeier LA, Dutzan N, Smith PC and Kraan H (2022) Editorial: Immunology of the Oral Mucosa. Front. Immunol. 13:877209. doi: 10.3389/fimmu.2022.877209
Received: 16 February 2022; Accepted: 04 March 2022;
Published: 25 March 2022.
Edited and reviewed by:
Nils Yngve Lycke, University of Gothenburg, SwedenCopyright © 2022 Bergmeier, Dutzan, Smith and Kraan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lesley Ann Bergmeier, bC5hLmJlcmdtZWllckBxbXVsLmFjLnVr